Loss of CEACAM1 in hepatocytes causes hepatic fibrosis.
Zaidi S, Asalla S, Muturi HT, Russo L, Abdolahipour R, Belew GD, Iglesias MB, Feraudo M, Leon L, Kuo E, Liu X, Kumarasamy S, Ghadieh HE, Gatto-Weis C, Zarrinpar A, Duarte S, Najjar SM., Free PMC Article

Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation.
Muturi HT, Ghadieh HE, Asalla S, Lester SG, Belew GD, Zaidi S, Abdolahipour R, Shrestha AP, Portuphy AO, Stankus HL, Helal RA, Verhulst S, Duarte S, Zarrinpar A, van Grunsven LA, Friedman SL, Schwabe RF, Hinds TD Jr, Kumarasamy S, Najjar SM., Free PMC Article

Spliced CEACAM1: A Potential Novel Biomarker and Target for Ameliorating Liver Ischemia-reperfusion Injury.
Yazdani HO, Geller DA, Tohme S.

The role of carcinoembryonic antigen-related cell adhesion molecule 1 in cancer.
Götz L, Rueckschloss U, Balk G, Pfeiffer V, Ergün S, Kleefeldt F., Free PMC Article

Alternative splicing of CEACAM1 by hypoxia-inducible factor-1α enhances tolerance to hepatic ischemia in mice and humans.
Dery KJ, Kojima H, Kageyama S, Kadono K, Hirao H, Cheng B, Zhai Y, Farmer DG, Kaldas FM, Yuan X, Eltzschig HK, Kupiec-Weglinski JW., Free PMC Article

Human CEACAM1 is targeted by a Streptococcus pyogenes adhesin implicated in puerperal sepsis pathogenesis.
Catton EA, Bonsor DA, Herrera C, Stålhammar-Carlemalm M, Lyndin M, Turner CE, Soden J, van Strijp JAG, Singer BB, van Sorge NM, Lindahl G, McCarthy AJ., Free PMC Article

CEACAM1 Is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Clear Cell Renal Cell Carcinoma.
Yang L, Liu Y, Zhang B, Yu M, Huang F, Zeng J, Lu Y, Yang C., Free PMC Article

NLR family CARD domain containing 5 promotes hypoxia-induced cancer progress and carboplatin resistance by activating PI3K/AKT via carcinoembryonic antigen related cell adhesion molecule 1 in non-small cell lung cancer.
Dong Y, Xu T, Li D, Guo H, Du X, Li G, Chen J, Wang B, Wang P, Yu G, Zhao X, Xue R., Free PMC Article

TIM3/CEACAM1 pathway involves in myeloid-derived suppressor cells induced CD8(+) T cells exhaustion and bone marrow inflammatory microenvironment in myelodysplastic syndrome.
Yu S, Ren X, Meng F, Guo X, Tao J, Zhang W, Liu Z, Fu R, Li L.

Increased CEACAM1 expression on peripheral blood neutrophils in patients with rheumatoid arthritis.
Matsumoto H, Fujita Y, Onizawa M, Saito K, Sumichika Y, Yoshida S, Temmoku J, Matsuoka N, Yashiro-Furuya M, Asano T, Sato S, Suzuki E, Machida T, Watanabe H, Migita K., Free PMC Article

Glycan Conformation in the Heavily Glycosylated Protein, CEACAM1.
Rogals MJ, Eletsky A, Huang C, Morris LC, Moremen KW, Prestegard JH., Free PMC Article

Structural analysis of human CEACAM1 oligomerization.
Gandhi AK, Sun ZJ, Huang YH, Kim WM, Yang C, Petsko GA, Beauchemin N, Blumberg RS., Free PMC Article

Transfer RNA-derived fragment 5'tRF-Gly promotes the development of hepatocellular carcinoma by direct targeting of carcinoembryonic antigen-related cell adhesion molecule 1.
Liu D, Wu C, Wang J, Zhang L, Sun Z, Chen S, Ding Y, Wang W., Free PMC Article

Elevation of neutrophil carcinoembryonic antigen-related cell adhesion molecule 1 associated with multiple inflammatory mediators was related to different clinical stages in ischemic stroke patients.
Zhang Y, Wang Y, Wu W, Liu P, Sun S, Hong M, Yuan Y, Xia Q, Chen Z., Free PMC Article

Human CEACAM1 N-domain dimerization is independent from glycan modifications.
Belcher Dufrisne M, Swope N, Kieber M, Yang JY, Han J, Li J, Moremen KW, Prestegard JH, Columbus L., Free PMC Article

T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction.
Pinkert J, Boehm HH, Trautwein M, Doecke WD, Wessel F, Ge Y, Gutierrez EM, Carretero R, Freiberg C, Gritzan U, Luetke-Eversloh M, Golfier S, Von Ahsen O, Volpin V, Sorrentino A, Rathinasamy A, Xydia M, Lohmayer R, Sax J, Nur-Menevse A, Hussein A, Stamova S, Beckmann G, Glueck JM, Schoenfeld D, Weiske J, Zopf D, Offringa R, Kreft B, Beckhove P, Willuda J., Free PMC Article

Antibody ligation of CEACAM1, CEACAM3, and CEACAM6, differentially enhance the cytokine release of human neutrophils in responses to Candida albicans.
Klaile E, Prada Salcedo JP, Klassert TE, Besemer M, Bothe AK, Durotin A, Müller MM, Schmitt V, Luther CH, Dittrich M, Singer BB, Dandekar T, Slevogt H.

Altered splicing associated with the pathology of inflammatory bowel disease.
Berger K, Somineni H, Prince J, Kugathasan S, Gibson G., Free PMC Article

Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer.
Moriyama J, Oshima Y, Nanami T, Suzuki T, Yajima S, Shiratori F, Funahashi K, Shimada H.

Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36.
Chean J, Chen CJ, Gugiu G, Wong P, Cha S, Li H, Nguyen T, Bhatticharya S, Shively JE., Free PMC Article

Phosphorylation of human CEACAM1-LF by PKA and GSK3β promotes its interaction with β-catenin.
Hu W, Bagramyan K, Bhatticharya S, Hong T, Tapia A, Wong P, Kalkum M, Shively JE., Free PMC Article

Evaluation of carcinoembryonic antigen-related cell adhesion molecule 1 blood serum levels in women at high risk for preeclampsia.
Mach P, Andrikos D, Schmidt B, Gellhaus A, Rusch P, Birdir C, Andrikos A, Schmitt V, Kimmig R, Singer BB, Köninger A.

Up-regulation of microRNA-30b/30d cluster represses hepatocyte apoptosis in mice with fulminant hepatic failure by inhibiting CEACAM1.
Zhao C, Dang Z, Sun J, Yuan S, Xie L.

Bacterial protein domains with a novel Ig-like fold target human CEACAM receptors.
van Sorge NM, Bonsor DA, Deng L, Lindahl E, Schmitt V, Lyndin M, Schmidt A, Nilsson OR, Brizuela J, Boero E, Sundberg EJ, van Strijp JAG, Doran KS, Singer BB, Lindahl G, McCarthy AJ., Free PMC Article

TIM-3 drives temporal differences in restimulation-induced cell death sensitivity in effector CD8(+) T cells in conjunction with CEACAM1.
Lake CM, Voss K, Bauman BM, Pohida K, Jiang T, Dveksler G, Snow AL., Free PMC Article